Type Congenic; Mutant Strain; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Additional information on Congenic nomenclature. Mating System +/+ sibling x Heterozygote (Female x Male) 16-DEC-08 Species laboratory mouse Generation N10 (27-OCT-09)
Generation DefinitionsDonating Investigator IMR Colony, The Jackson Laboratory Description
Mice homozygous for this dopamine transporter IRES-cre (DATIREScre) mutant allele are viable and fertile. Cre recombinase activity is observed as early as embryonic day 15, and co-localizes with endogenous gene expression in adult dopaminergic cell groups (substantia nigra (SN) and ventral tegmental area (VTA), as well as in the retrorubral field). Lesser Cre recombinase activity occurs in adult olfactory bulb glomeruli, mimicking the known lower Slc6a3 (or DAT) expression in this tissue. Although the pattern and intensity of DAT immunostaining in the SN, VTA and striatum do not differ between wild-type and mutant mice, striatum DAT protein levels are moderately reduced (17%) in heterozygotes and significantly reduced (47%) in homozygotes. This diminution in homozygous striatum is associated with significantly increased neuropeptide PDyn (but not D1, D2, or PPE) mRNA levels compared to wild-type, while such an increase is not observed in heterozygotes. When bred with mice containing a loxP-flanked sequence of interest, Cre-mediated recombination will result in deletion of the flanked genome in dopaminergic neurons. As such, these mutant mice may be useful in neurobiological studies to facilitate the analysis of gene function in dopaminergic neurons, such as drug addiction or Parkinson's disease.In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. It should be noted that the phenotype could vary from that originally described. The strain description will be modified as published results become available.
Development
To co-express both genes from the endogenous promoter (and minimize interference with endogenous gene function), a targeting vector was designed to insert an internal ribosome entry site-linked Cre recombinase gene (IRES-Cre) and FRT-flanked PGK-neo cassette 23 bp downstream from the stop codon of the endogenous gene. The construct was electroporated into C57BL/6-derived CMT2 embryonic stem (ES) cells. Correctly targeted ES cells were injected into blastocysts and chimeric mice were bred to C57BL/6 mice. The FRT-flanked neo cassette was removed in the germline mice by intercrossing with a Flpe-deleter strain on a mixed B6;SJL background (see Stock No. 003800). The resulting mutant offspring (now harboring this DATIREScre allele) were maintained on this mixed genetic background prior to arrival at The Jackson Laboratory. Upon arrival, mice were backcrossed to the C57BL/6J inbred strain for at least five generations.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Parkinson's Disease Models
005987 129-Achetm1Loc/J 007587 129S-Park2tm1Rpa/J 002779 129S-Parp1tm1Zqw/J 004684 B6(129P2) Nos2tm1Lau-chtl/GrsrJ 004608 B6(Cg)-Htra2mnd2/J 008133 B6.129-Sncbtm1Sud/J 008084 B6.129P2-Drd4tm1Dkg/J 004744 B6.129P2-Esr1tm1Ksk/J 002609 B6.129P2-Nos2tm1Lau/J 008843 B6.129P2-Sncgtm1Vlb/J 004322 B6.129S1-Mapk10tm1Flv/J 003190 B6.129S2-Drd2tm1Low/J 006582 B6.129S4-Park2tm1Shn/J 005934 B6.129S4-Ucp2tm1Lowl/J 004936 B6.129S6(Cg)-Spp1tm1Blh/J 009346 B6.Cg-Lrrk2tm1.1Shn/J 005491 B6.Cg-Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J 006577 B6.Cg-Park7tm1Shn/J 000567 B6.Cg-T2J +/+ Qkqk/J 007004 B6.Cg-Tg(Camk2a-tTA)1Mmay/DboJ 003139 B6.Cg-Tg(DBHn-lacZ)8Rpk/J 007673 B6.Cg-Tg(Gad1-EGFP)3Gfng/J 008323 B6.Cg-Tg(Mc4r-MAPT/Sapphire)21Rck/J 008321 B6.Cg-Tg(Npy-MAPT/Sapphire)1Rck/J 008324 B6.Cg-Tg(Pmch-MAPT/Topaz)1Rck/J 008322 B6.Cg-Tg(Pomc-MAPT/Topaz)1Rck/J 007894 B6.Cg-Tg(Rgs4-EGFP)4Lvt/J 008135 B6.Cg-Tg(THY1-SNCA*A53T)M53Sud/J 008601 B6.Cg-Tg(Th-cre)1Tmd/J 000544 B6.D2-Cacna1atg/J 008364 B6;129-Chattm1(cre/Esr1)Nat/J 009688 B6;129-Dbhtm2(Th)Rpa Thtm1Rpa/J 008883 B6;129-Gt(ROSA)26Sortm1(SNCA*A53T)Djmo/TmdJ 008889 B6;129-Gt(ROSA)26Sortm2(SNCA*119)Djmo/TmdJ 008886 B6;129-Gt(ROSA)26Sortm3(SNCA*E46K)Djmo/TmdJ 009347 B6;129-Lrrk2tm1.1Shn/J 004807 B6;129-Psen1tm1Mpm Tg(APPSwe,tauP301L)1Lfa/J 006390 B6;129-Sncatm1Sud Sncbtm1.1Sud/J 008532 B6;129-Thtm1(cre/Esr1)Nat/J 008333 B6;129P2-Dldtm1Ptl/J 008333 B6;129P2-Dldtm1Ptl/J 002596 B6;129P2-Nos2tm1Lau/J 003243 B6;129S-Tnfrsf1atm1Imx Tnfrsf1btm1Imx/J 003692 B6;129X1-Sncatm1Rosl/J 008169 B6;C3-Tg(Prnp-MAPT*P301S)PS19Vle/J 004479 B6;C3-Tg(Prnp-SNCA*A53T)83Vle/J 000231 B6;C3Fe a/a-Csf1op/J 008473 B6;SJL-Tg(THY1-SNCA*A30P)M30Sud/J 008134 B6;SJL-Tg(THY1-SNCA*A30P)TS2Sud/J 000506 B6C3Fe a/a-Qkqk/J 003741 B6D2-Tg(Prnp-MAPT)43Vle/J 008389 C57BL/6-Tg(THY1-SNCA)1Sud/J 005706 C57BL/6-Tg(tetO-CDK5R1/GFP)337Lht/J 006618 C57BL/6-Tg(tetO-COX8A/EYFP)1Ksn/J 007677 CB6-Tg(Gad1-EGFP)G42Zjh/J 009610 FVB/N-Tg(LRRK2)1Cjli/J 009604 FVB/N-Tg(LRRK2*R1441G)135Cjli/J 009090 FVB/NJ-Tg(Slc6a3-PARK2*Q311X)AXwy/J 010710 FVB;129S6-Sncatm1Nbm Tg(SNCA)1Nbm/J 010788 FVB;129S6-Sncatm1Nbm Tg(SNCA*A30P)1Nbm Tg(SNCA*A30P)2Nbm/J 010799 FVB;129S6-Sncatm1Nbm Tg(SNCA*A53T)1Nbm Tg(SNCA*A53T)2Nbm/J 004808 STOCK Mapttm1(EGFP)Klt Tg(MAPT)8cPdav/J 000942 STOCK Pitx3ak/2J 006340 STOCK Tg(Gad1-EGFP)98Agmo/J 008474 STOCK Tg(THY1-SNCA*A53T)F53Sud/J 008132 STOCK Tg(THY1-Snca)M1mSud/J View Parkinson's Disease Models (66 strains)
Strains carrying other alleles of Slc6a3
009090 FVB/NJ-Tg(Slc6a3-PARK2*Q311X)AXwy/J View Strains carrying other alleles of Slc6a3 (1 strain)
Strains carrying other alleles of cre
004337 129(Cg)-Foxg1tm1(cre)Skm/J 008569 129-Alpltm1(cre)Nagy/J 003328 129-Tg(Prm-cre)58Og/J 005989 129;FVB-Tg(PTH-cre)4167Slib/J 007179 129S.Cg-Tg(UBC-cre/ESR1)1Ejb/J 007915 129S.FVB-Tg(Amh-cre)8815Reb/J 004302 129S1/Sv-Hprttm1(cre)Mnn/J 003960 129S6-Tg(Prnp-GFP/cre)1Blw/J 005697 B6.129-Otx1tm4(cre)Asim/J 004146 B6.129-Tg(Pcp2-cre)2Mpin/J 006785 B6.129P2(C)-Cd19tm1(cre)Cgn/J 006084 B6.129P2(Cg)-Foxg1tm1(cre)Skm/J 008710 B6.129P2-Hprttm10(Ple162-EGFP/cre)Ems/J 008877 B6.129P2-Hprttm12(Ple177-EGFP/cre)Ems/J 008709 B6.129P2-Hprttm9(Ple178-EGFP/cre)Ems/J 004781 B6.129P2-Lyz2tm1(cre)Ifo/J 005623 B6.129S-Shhtm2(cre/ESR1)Cjt/J 006600 B6.129S1-Mnx1tm4(cre)Tmj/J 005628 B6.129S2-Emx1tm1(cre)Krj/J 003755 B6.129S4-Meox2tm1(cre)Sor/J 006878 B6.129S6-Taglntm2(cre)Yec/J 006054 B6.C-Tg(CMV-cre)1Cgn/J 009642 B6.Cg(129)-Tg(Gh1-cre)1Sac/J 006230 B6.Cg-Cebpatm1Dgt Tg(Mx1-cre)1Cgn/J 005622 B6.Cg-Shhtm1(EGFP/cre)Cjt/J 006149 B6.Cg-Tg(ACTA1-cre)79Jme/J 003574 B6.Cg-Tg(Alb-cre)21Mgn/J 006881 B6.Cg-Tg(Aqp2-cre)1Dek/J 004682 B6.Cg-Tg(CAG-cre/Esr1)5Amc/J 008520 B6.Cg-Tg(CD2-cre)4Kio/J 009350 B6.Cg-Tg(CDX2-cre)101Erf/J 009352 B6.Cg-Tg(CDX2-cre*)189Erf/J 005359 B6.Cg-Tg(Camk2a-cre)T29-1Stl/J 012237 B6.Cg-Tg(Cdh16-cre)91Igr/J 006137 B6.Cg-Tg(Cdh5-cre)7Mlia/J 006368 B6.Cg-Tg(Cr2-cre)3Cgn/J 006663 B6.Cg-Tg(Eno2-cre)39Jme/J 005069 B6.Cg-Tg(Fabp4-cre)1Rev/J 003573 B6.Cg-Tg(Ins2-cre)25Mgn/J 008068 B6.Cg-Tg(Itgax-cre)1-1Reiz/J 008781 B6.Cg-Tg(Kap-cre)29066/2Sig/J 003802 B6.Cg-Tg(Lck-cre)548Jxm/J 006889 B6.Cg-Tg(Lck-cre)I540Jxm/J 009643 B6.Cg-Tg(Lhb-cre)1Sac/J 003556 B6.Cg-Tg(Mx1-cre)1Cgn/J 007742 B6.Cg-Tg(Myh11-cre,-EGFP)2Mik/J 005657 B6.Cg-Tg(Myh6-cre/Esr1)1Jmk/J 008205 B6.Cg-Tg(NPHS2-cre)295Lbh/J 003771 B6.Cg-Tg(Nes-cre)1Kln/J 005975 B6.Cg-Tg(Plp1-cre/ESR1)3Pop/J 008827 B6.Cg-Tg(Prdm1-cre)1Masu/J 005584 B6.Cg-Tg(Prrx1-cre)1Cjt/J 003967 B6.Cg-Tg(Rbp3-cre)528Jxm/J 009613 B6.Cg-Tg(Scnn1a-cre)3Aibs/J 008454 B6.Cg-Tg(Sox2-cre)1Amc/J 006361 B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J 003966 B6.Cg-Tg(Syn1-cre)671Jxm/J 004128 B6.Cg-Tg(Tek-cre)12Flv/J 008863 B6.Cg-Tg(Tek-cre)1Ywa/J 008601 B6.Cg-Tg(Th-cre)1Tmd/J 007606 B6.Cg-Tg(Thy1-cre/ESR1,-EYFP)AGfng/J 008085 B6.Cg-Tg(UBC-cre/ESR1)1Ejb/J 008610 B6.Cg-Tg(Vav1-cre)A2Kio/J 008735 B6.Cg-Tg(Wap-cre)11738Mam/JKnwJ 005947 B6.Cg-Tg(Wap-cre)11738Mam/JKnwPea 009614 B6.Cg-Tg(Wfs1-cre/ERT2)2Aibs/J 006234 B6.Cg-Tg(tetO-cre)1Jaw/J 006475 B6.FVB(129S4)-Tg(Ckmm-cre)5Khn/J 006451 B6.FVB(129X1)-Tg(Sim1-cre)1Lowl/J 006333 B6.FVB(Cg)-Tg(Neurog3-cre)C1Able/J 003724 B6.FVB-Tg(EIIa-cre)C5379Lmgd/J 010714 B6.FVB-Tg(Pomc-cre)1Stl/J 003394 B6.FVB-Tg(Zp3-cre)3Mrt/J 004586 B6.SJL-Tg(Vil-cre)997Gum/J 003552 B6129-Tg(Wap-cre)11738Mam/J 004847 B6;129-Gt(ROSA)26Sortm1(cre/Esr1)Nat/J 008876 B6;129-Hprttm11(Ple176-EGFP/cre)Ems/J 005549 B6;129-Pax3tm1(cre)Joe/J 005650 B6;129-Tg(Myh6-cre/Esr1)1Jmk/J 008529 B6;129P-Tg(Neurog1-cre/ESR1)1Good/J 006668 B6;129P2-Omptm4(cre)Mom/MomJ 007001 B6;129S-Tg(UBC-cre/ESR1)1Ejb/J 006410 B6;129S6-Chattm1(cre)Lowl/J 009616 B6;C3-Tg(A930038C07Rik-cre)4Aibs/J 008844 B6;C3-Tg(Ctgf-cre)2Aibs/J 008839 B6;C3-Tg(Cyp39a1-cre)1Aibs/J 009117 B6;C3-Tg(Cyp39a1-cre)7Aibs/J 008848 B6;C3-Tg(Mybpc1-cre)2Aibs/J 009111 B6;C3-Tg(Scnn1a-cre)1Aibs/J 009112 B6;C3-Tg(Scnn1a-cre)2Aibs/J 009103 B6;C3-Tg(Wfs1-cre/ERT2)3Aibs/J 003466 B6;D2-Tg(Sycp1-cre)4Min/J 008533 B6;FVB-Tg(Cspg4-cre)1Akik/J 003734 B6;FVB-Tg(GZMB-cre)1Jcb/J 004426 B6;SJL-Tg(Cga-cre)3Sac/J 003554 B6;SJL-Tg(Col2a1-cre)1Bhr/J 005249 B6;SJL-Tg(Krt1-15-cre/PGR)22Cot/J 007610 B6;SJL-Tg(Thy1-cre/ESR1,-EYFP)VGfng/J 007252 B6Ei.129S4-Tg(Prm-cre)58Og/EiJ 003465 BALB/c-Tg(CMV-cre)1Cgn/J 004126 C.Cg-Cd19tm1(cre)Cgn Ighb/J 005673 C.Cg-Tg(Mx1-cre)1Cgn/J 006244 C.Cg-Tg(tetO-cre)1Jaw/J 008766 C57BL/6-Tg(Cd8a-cre)1Itan/J 011062 C57BL/6-Tg(Gdf9-cre)5092Coo/J 006474 C57BL/6-Tg(Grik4-cre)G32-4Stl/J 008314 C57BL/6-Tg(HBB-cre)12Kpe/J 008870 C57BL/6-Tg(Hspa2-cre)1Eddy/J 008535 C57BL/6-Tg(Pf4-cre)Q3Rsko/J 006888 C57BL/6-Tg(Zp3-cre)1Gwh/J 003651 C57BL/6-Tg(Zp3-cre)93Knw/J 007567 C57BL/6J-Tg(Itgax-cre,-EGFP)4097Ach/J 008661 C57BL/6J-Tg(Nkx2-1-cre)2Sand/J 011034 FVB(Cg)-Tg(Ghrhr-cre)3242Lsk/J 006405 FVB-Tg(Ckmm-cre)5Khn/J 006774 FVB-Tg(Col2a1-cre/ESR1)KA3Smac/J 006954 FVB-Tg(Ddx4-cre)1Dcas/J 004600 FVB-Tg(GFAP-cre)25Mes/J 006364 FVB-Tg(Nr5a1-cre)2Lowl/J 008537 FVB-Tg(Tek-cre)2352Rwng/J 006139 FVB.Cg-Tg(ACTA1-cre)79Jme/J 006297 FVB.Cg-Tg(Eno2-cre)39Jme/J 008244 FVB.Cg-Tg(tetO-cre)1Jaw/J 003376 FVB/N-Tg(ACTB-cre)2Mrt/J 003314 FVB/N-Tg(EIIa-cre)C5379Lmgd/J 006143 FVB/N-Tg(Thy1-cre)1Vln/J 003377 FVB/N-Tg(Zp3-cre)3Mrt/J 005732 NOD.Cg-Tg(Lck-cre)548Jxm/AchJ 008694 NOD/ShiLt-Tg(Foxp3-EGFP/cre)1cJbs/J 004986 NOD/ShiLt-Tg(Ins2-cre)3Lt/Lt 003855 NOD/ShiLt-Tg(Ins2-cre)5Lt/LtJ 004987 NOD/ShiLt-Tg(Ins2-cre)6Lt/Lt 008464 STOCK Foxa2tm2.1(cre/Esr1)Moon/J 004192 STOCK Mttptm2Sgy Ldlrtm1Her Apobtm2Sgy Tg(Mx1-cre)1Cgn/J 006677 STOCK Olfr151tm28Mom/MomJ 007684 STOCK Tg(Atoh1-cre/ESR1)14Fsh/J 004453 STOCK Tg(CAG-cre/Esr1)5Amc/J 009615 STOCK Tg(Cartpt-cre)1Aibs/J 005105 STOCK Tg(Chx10-EGFP/cre,-ALPP)2Clc/J 008861 STOCK Tg(Ela1-Cre/ESR1)1Stof/J 005938 STOCK Tg(Eno2-cre)39Jme/J 004692 STOCK Tg(Hoxb7-cre)13Amc/J 008122 STOCK Tg(Ins2-cre/Esr1)1Dam/J 004782 STOCK Tg(KRT14-cre)1Amc/J 005107 STOCK Tg(KRT14-cre/Esr1)20Efu/J 008582 STOCK Tg(Kcnc2-Cre)K128Stl/LetJ 003551 STOCK Tg(MMTV-cre)1Mam/J 003553 STOCK Tg(MMTV-cre)4Mam/J 002527 STOCK Tg(Mx1-cre)1Cgn/J 009074 STOCK Tg(Myh6-cre)1Jmk/J 009102 STOCK Tg(Nefh-cre)12Kul/J 002858 STOCK Tg(Nes-cre)1Wme/J 002859 STOCK Tg(Nes-cre)2Wme/J 005667 STOCK Tg(Neurog3-cre)C1Able/J 008119 STOCK Tg(Neurog3-cre/Esr1)1Dam/J 006207 STOCK Tg(Pcp2-cre)1Amc/J 005965 STOCK Tg(Pomc1-cre)16Lowl/J 006395 STOCK Tg(Sim1-cre)1Lowl/J 009606 STOCK Tg(Six2-EGFP/cre)1Amc/J 004783 STOCK Tg(Sox2-cre)1Amc/J 008208 STOCK Tg(Stra8-cre)1Reb/J 004746 STOCK Tg(Tagln-cre)1Her/J 003829 STOCK Tg(Wnt1-cre)11Rth Tg(Wnt1-GAL4)11Rth/J 007807 STOCK Tg(Wnt1-cre)11Rth/MileJ 008199 STOCK Tg(dlx6a-cre)1Mekk/J 002471 STOCK Tg(hCMV-cre)140Sau/J 006224 STOCK Tg(tetO-cre)1Jaw/J View Strains carrying other alleles of cre (167 strains)
Introduction to Cre-lox technology
Visit the Parkinson's Disease Resource site for helpful information on Parkinson's and research resources.
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Slc6a3tm1.1(cre)Bkmn/Slc6a3tm1.1(cre)Bkmn
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
- normal phenotype
- no abnormal phenotype detected
- homozygous and heterozygous mice are normal and viable (MGI Ref ID J:114466)
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
cre relatedCell Biology Research
Channel and Transporter Defects
Neurobiology Research
Behavioral and Learning Defects
Channel and Transporter Defects
Neurotransmitter Receptor and Synaptic Vesicle Defects
Research Tools
Cre-lox System
Cre Recombinase Expression
Cre Recombinase Expression: Germline/Embryonic Expression
Genetics Research
Mutagenesis and Transgenesis: Cre-lox System
Slc6a3tm1.1(cre)Bkmn relatedResearch Tools
Cre-lox System
Genetics Research
Mutagenesis and Transgenesis: Cre-lox System
Neurobiology Research
Parkinson's Disease
strains expressing cre
| Allele Symbol | Slc6a3tm1.1(cre)Bkmn | ||
|---|---|---|---|
| Allele Name | targeted mutation 1.1, Cristina M Backman | ||
| Allele Type | Targeted (knock-in) | ||
| Common Name(s) | DatIREScre; | ||
| Mutation Made By | Andreas Tomac, National Institute on Drug Abuse (NIH) | ||
| ES Cell Line Name | Other (see notes) | ||
| Site of Expression | Cre recombinase activity is observed as early as embryonic day 15, and co-localizes with endogenous gene expression in adult dopaminergic cell groups (substantia nigra (SN) and ventral tegmental area (VTA), as well as in the retrorubral field). Lesser Cre recombinase activity occurs in adult olfactory bulb glomeruli, mimicking the known lower Slc6a3 (or DAT) expression in this tissue. | ||
| Expressed Gene | cre, cre recombinase, bacteriophage P1 | ||
| Cre recombinase is an enzyme derived from the bacteriophage P1 that specifically recognizes loxP sites. Cre has been shown to effectively mediate the excision of DNA located between loxP sites. After the excision event, the DNA ends recombine leaving a single loxP site in place of the intervening sequence. | |||
| Gene Symbol and Name | Slc6a3, solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | ||
| Chromosome | 13 | ||
| Gene Common Name(s) | DAT; DAT1; Dat1; dopamine transporter 1; | ||
| Driver Note | Slc6a3 | ||
| General Note | The targeting vector was electroporated into both R1 and C57BL/6 ES cells. | ||
| Molecular Note | An FRT-flanked neo was removed from the locus, leaving cre recombinase cDNA in the 3' UTR to allow bicistronic mRNA expression. [MGI Ref ID J:114466] | ||
Genotyping Protocols
Slc6a3tm1.1(cre)Bkmn, Melt Curve Analysis
Slc6a3tm1.1(cre)Bkmn, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Backman CM; Malik N; Zhang Y; Shan L; Grinberg A; Hoffer BJ; Westphal H; Tomac AC. 2006. Characterization of a mouse strain expressing Cre recombinase from the 3' untranslated region of the dopamine transporter locus. Genesis 44(8):383-90. [PubMed: 16865686] [MGI Ref ID J:114466]
Slc6a3tm1.1(cre)Bkmn relatedDiaz-Ruiz O; Zapata A; Shan L; Zhang Y; Tomac AC; Malik N; de la Cruz F; Backman CM. 2009. Selective deletion of PTEN in dopamine neurons leads to trophic effects and adaptation of striatal medium spiny projecting neurons. PLoS One 4(9):e7027. [PubMed: 19750226] [MGI Ref ID J:153622]
Animal Health Reports
Room Number AX11
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, heterozygous mice are bred to wildtype siblings or to inbred C57BL/6J (Stock No. 000664). Homozygous mice have approximately half of the endogenous gene expression associated with altered neuropeptide levels in the brain, while heterozygotes have a moderate, non-significant reduction in endogenous gene expression with no reported neuropeptide abnormalities. Mating System +/+ sibling x Heterozygote (Female x Male) 16-DEC-08 Diet Information LabDiet® 5K52/5K67
| Pricing for USA, Canada and Mexico shipping destinations |
|
![]() |
Price (US dollars $) Gender Genotypes Provided Individual Mouse $243.50 Female or Male Heterozygous for Slc6a3tm1.1(cre)Bkmn
Pairs /Price (US dollars $) Pair Genotype $297.85 Heterozygous for Slc6a3tm1.1(cre)Bkmn x Wild-type for Slc6a3tm1.1(cre)Bkmn $297.85 Wild-type for Slc6a3tm1.1(cre)Bkmn x Heterozygous for Slc6a3tm1.1(cre)Bkmn Standard Supply
Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of approximately nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and/or larger quantities of mice may be possible. Estimated ship dates for all orders provided within two business days following order placement.
Supply Notes
- Usually shipped between four and eight weeks of age.
| Pricing for International shipping destinations |
|
![]() |
Price (US dollars $) Gender Genotypes Provided Individual Mouse $316.60 Female or Male Heterozygous for Slc6a3tm1.1(cre)Bkmn
Pairs /Price (US dollars $) Pair Genotype $387.30 Heterozygous for Slc6a3tm1.1(cre)Bkmn x Wild-type for Slc6a3tm1.1(cre)Bkmn $387.30 Wild-type for Slc6a3tm1.1(cre)Bkmn x Heterozygous for Slc6a3tm1.1(cre)Bkmn Standard Supply
Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of approximately nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and/or larger quantities of mice may be possible. Estimated ship dates for all orders provided within two business days following order placement.
Supply Notes
- Usually shipped between four and eight weeks of age.
|
|
Repository-Live. A collection of over 1000 strains maintained as live colonies. Individual colonies are sized to meet current customer demand. Delivery for orders of 10 mice or less ranges on average from one to eight weeks; mice are generally shipped between four to six weeks of age with a maximum shipping age of approximately nine weeks. Colony sizes do not generally support stringent age specifications for large volumes of mice; however custom orders and/or larger quantities of mice may be possible. Estimated ship dates for all orders provided within two business days following order placement.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Strain(s) not available to companies or for-profit entities.
- Strain(s) not available to companies or for-profit entities.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.